CMU and Healthcare System, in collaboration with Kyoto University, have launched a global research center to advance cancer treatment, regenerative medicine, and AI-powered drug discovery.
A breakthrough includes the world’s first allogeneic CAR-T therapy for solid cancers, developed by Ever Supreme Bio-Technology, achieving over 90% tumor reduction in pre-clinical studies. Human trials are underway, with FDA approval marking a key milestone.
CMU’s AI-driven innovations also enhance healthcare with smart diagnostics, tele-ICU systems, and AI-assisted medical record management, reinforcing Taiwan’s role in cutting-edge medical advancements.
